Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18-49 Years of Age. (Q47625853)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18-49 Years of Age.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28968871

Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18-49 Years of Age. (English)

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28968871

influenza vaccine

1 reference

based on heuristic

inferred from title

author name string

Lisa M Dunkle

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28968871

Ruvim Izikson

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28968871

Peter A Patriarca

3

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28968871

Karen L Goldenthal

4

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28968871

Derek Muse

5

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28968871

Manon M J Cox

6

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28968871

language of work or name

0 references

publication date

9 September 2017

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28968871

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Journal of Infectious Diseases

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28968871

216

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28968871

1219-1226

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28968871

10

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28968871

A fast track influenza virus vaccine produced in insect cells

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Randomized comparison of the safety of Flublok(®) versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥ 50 years of age.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Sex differences in injection site reactions with human vaccines

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

The rationale for quadrivalent influenza vaccines

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Standardization of Hemagglutination Inhibition Assay for Influenza Serology Allows for High Reproducibility between Laboratories

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIX478

21 January 2018

Identifiers

10.1093/INFDIS/JIX478

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28968871

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28968871

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47625853&oldid=1771745527"